Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PAK1 inhibitors(PAK protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H23N5O3 |
InChIKeyYCYAGMMAFHPTQQ-JXAWBTAJSA-N |
CAS Registry2489878-55-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | 01 Sep 2020 |